Banque Pictet & Cie Sa Moderna, Inc. Transaction History

Banque Pictet & Cie Sa

$13.1 Billion
Q3 2024

A detailed history of Banque Pictet & Cie Sa transactions in Moderna, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 3,155,399 shares of MRNA stock, worth $124 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

3,155,399

Previous 3,154,429 0.03%

Holding current value

$124 Million

Previous $375 Million 43.7%

% of portfolio

1.61%

Previous 3.41%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$63.64 - $125.14 $61,730 - $121,385	970 Added 0.03%	3,155,399 $211 Million
Q2 2024 Jul 25, 2024	SELL	$101.21 - $166.61 $738,833 - $1.22 Million	-7,300 Reduced 0.23%	3,154,429 $375 Million
Q1 2024 May 06, 2024	BUY	$85.37 - $115.44 $2.35 Million - $3.17 Million	27,500 Added 0.88%	3,161,729 $337 Million
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $639,352 - $960,547	-9,198 Reduced 0.29%	3,134,229 $312 Million
Q3 2023 Nov 02, 2023	BUY	$96.41 - $126.61 $4.61 Million - $6.05 Million	47,788 Added 1.54%	3,143,427 $325 Million
Q2 2023 Aug 04, 2023	SELL	$118.5 - $160.53 $1.56 Million - $2.12 Million	-13,196 Reduced 0.42%	3,095,639 $376 Million
Q1 2023 May 01, 2023	BUY	$135.66 - $197.02 $3.72 Million - $5.4 Million	27,398 Added 0.89%	3,108,835 $477 Million
Q4 2022 Feb 06, 2023	BUY	$118.38 - $210.04 $6.78 Million - $12 Million	57,256 Added 1.89%	3,081,437 $0
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $255,621 - $420,399	-2,165 Reduced 0.07%	3,024,181 $358 Billion
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $3.15 Million - $4.74 Million	26,863 Added 0.9%	3,026,346 $432 Million
Q1 2022 May 04, 2022	BUY	$126.46 - $235.05 $1.97 Million - $3.67 Million	15,604 Added 0.52%	2,999,483 $517 Million
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $4.41 Million - $7.2 Million	-19,530 Reduced 0.65%	2,983,879 $758 Million
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $3.05 Million - $6.67 Million	-13,760 Reduced 0.46%	3,003,409 $1.16 Billion
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $2.89 Million - $5.23 Million	-22,240 Reduced 0.73%	3,017,169 $709 Million
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $2.12 Million - $3.61 Million	19,400 Added 0.64%	3,039,409 $398 Million
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $8.71 Million - $22.5 Million	-132,437 Reduced 4.2%	3,020,009 $316 Million
Q3 2020 Nov 10, 2020	SELL	$54.34 - $94.85 $7.63 Million - $13.3 Million	-140,500 Reduced 4.27%	3,152,446 $223 Million
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $7 Million - $18.9 Million	-236,068 Reduced 6.69%	3,292,946 $211 Million
Q1 2020 Apr 30, 2020	SELL	$17.78 - $31.58 $6.82 Million - $12.1 Million	-383,523 Reduced 9.8%	3,529,014 $106 Million
Q4 2019 Feb 03, 2020	SELL	$13.93 - $21.28 $519,784 - $794,041	-37,314 Reduced 0.94%	3,912,537 $76.5 Million
Q3 2019 Nov 08, 2019	BUY	$12.26 - $18.07 $367,800 - $542,100	30,000 Added 0.77%	3,949,851 $62.9 Million
Q2 2019 Aug 07, 2019	BUY	$13.7 - $28.34 $53.7 Million - $111 Million	3,919,851 New	3,919,851 $57.4 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Moderna, Inc. Transaction History